Literature DB >> 1825665

Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages.

T F Zioncheck1, L M Powell, G C Rice, D L Eaton, R M Lawn.   

Abstract

Elevated plasma levels of lipoprotein(a), Lp(a), represent a major, inherited risk factor for coronary heart disease, although the mechanism of its action remains unknown. Lp(a) is distinguished from the related LDL particle by the addition of apolipoprotein(a), apo(a). The presence of this large glycoprotein is likely to affect the binding of the particle to the LDL receptor and/or other receptors which may contribute to the atherogenic potential of Lp(a). Here we demonstrate the binding to macrophages of Lp(a) and pure recombinant apo(a) protein, via a specific, high-affinity receptor. This binding could lead to foam cell formation and the localization of Lp(a) to atherosclerotic plaques.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825665      PMCID: PMC329863          DOI: 10.1172/JCI115079

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Simple modification of a commercial flow cytometer to triple laser excitation. Simultaneous five-color fluorescence detection.

Authors:  J D Woronicz; G C Rice
Journal:  J Immunol Methods       Date:  1989-06-21       Impact factor: 2.303

Review 2.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

3.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

Review 4.  Macrophage lipoprotein receptors.

Authors:  A M Fogelman; B J Van Lenten; C Warden; M E Haberland; P A Edwards
Journal:  J Cell Sci Suppl       Date:  1988

5.  Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping.

Authors:  D A Rappolee; D Mark; M J Banda; Z Werb
Journal:  Science       Date:  1988-08-05       Impact factor: 47.728

6.  Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.

Authors:  D Gavish; N Azrolan; J L Breslow
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

Authors:  J N Wilcox; K M Smith; S M Schwartz; D Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.

Authors:  D L Eaton; G M Fless; W J Kohr; J W McLean; Q T Xu; C G Miller; R M Lawn; A M Scanu
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

9.  Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.

Authors:  P C Harpel; B R Gordon; T S Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

10.  Lipoprotein(a) binds to fibronectin and has serine proteinase activity capable of cleaving it.

Authors:  E M Salonen; M Jauhiainen; L Zardi; A Vaheri; C Ehnholm
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  14 in total

1.  Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).

Authors:  C Sandholzer; G Feussner; J Brunzell; G Utermann
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  Lipoprotein(a)

Authors:  J Scott
Journal:  BMJ       Date:  1991-09-21

Review 3.  Lp(a): Addressing a Target for Cardiovascular Disease Prevention.

Authors:  Nestor Vasquez; Parag H Joshi
Journal:  Curr Cardiol Rep       Date:  2019-07-31       Impact factor: 2.931

4.  Enhanced macrophage uptake of lipoprotein(a) after Ca2+-induced aggregate-formation.

Authors:  S Tanaka; A Yashiro; H Tasaki; Y Nakashima
Journal:  Lipids       Date:  1998-04       Impact factor: 1.880

5.  Plasma anti-α-galactoside antibody mediates lipoprotein(a) binding to macrophages.

Authors:  Binu Sheela; Genu George; Geetha Mandagini; Padinjaradath S Appukuttan
Journal:  Glycoconj J       Date:  2016-08-19       Impact factor: 2.916

6.  Oxidized lipoprotein(a) and cardio-ankle vascular index (CAVI) in hypertensive subjects.

Authors:  Kazuhiko Kotani; Shingo Yamada; Toshiyuki Yamada; Kazuomi Kario; Nobuyuki Taniguchi
Journal:  Heart Vessels       Date:  2012-06-19       Impact factor: 2.037

7.  The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor.

Authors:  K M Argraves; K F Kozarsky; J T Fallon; P C Harpel; D K Strickland
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

8.  Resistance of lipoprotein(a) to lipid peroxidation induced by oxygenated free radicals produced by gamma radiolysis: a comparison with low-density lipoprotein.

Authors:  J L Beaudeux; M Gardes-Albert; J Delattre; A Legrand; F Rousselet; J Peynet
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

9.  The association between blood glucose and oxidized lipoprotein(a) in healthy young women.

Authors:  Kazuhiko Kotani; Shingo Yamada; Shuumarjav Uurtuya; Toshiyuki Yamada; Nobuyuki Taniguchi; Ikunosuke Sakurabayashi
Journal:  Lipids Health Dis       Date:  2010-09-21       Impact factor: 3.876

10.  The apolipoprotein B3304-3317 peptide as an inhibitor of the lipoprotein (a):apolipoprotein B-containing lipoprotein interaction.

Authors:  V N Trieu; U Olsson; W J McConathy
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.